---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-002400"
form_type: "8-K/A"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2025-04-02T23:59:59+00:00"
generated_at: "2026-05-24T00:04:15.483860+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharmaceuticals regains full Nasdaq compliance after $8.3M raise and debt conversion

## Summary
- Submitted pro-forma financials showing stockholder's equity of $2.8M vs $2.5M minimum required.
- Raised $8.332M from at-the-market offering; converted $1.785M debt into 924,200 shares.
- Compliant with Market Value of Publicly Held Securities standard (>$1M) as of March 7, 2025.
- Nasdaq Capital Market Equity Standard compliance achieved as of March 31, 2025 and continuing.

## SEC filing metadata
- accession: 0001641172-25-002400
- form_type: 8-K/A
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2025-04-02T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000164117225002400/0001641172-25-002400-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000164117225002400/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-002400
- JSON: https://secwatch.observer/filing/0001641172-25-002400.json
- Plain text: https://secwatch.observer/filing/0001641172-25-002400.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.